跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,540 条关于
“BRI-50460”
全部
5,540
临床试验
4,848
药物
444
机构
57
资讯
191
2个月前
V-SYNTHES2 Enables Physics-Based Virtual Screening of 36 Billion Compounds for Challenging Drug Targets
去年
Body Roundness Index Predicts Cardiovascular Disease Risk in Chinese Adults
去年
Fezolinetant Shows Promising Body Composition Benefits for Menopausal Women in Phase 3 Trials
去年
Pakistan Approves Chinese Biosimilar Cancer Drug to Expand Access to Affordable Bevacizumab Treatment
去年
China Establishes Initial Pricing Mechanism for New Drugs to Boost Innovation Returns
去年
MIT Develops Ultrasound Bra for At-Home Breast Cancer Detection
去年
Brii Bio's BRII-179 Shows Promise in Identifying Responders for HBV Functional Cure
去年
Boundless Bio Prioritizes BBI-355 and New ecDTx Program, Discontinues BBI-825 Development
去年
Brii Biosciences Licenses Novel Antibiotic BRII-693 to Joincare Group for Greater China Market
去年
Brii Bio Acquires Full Rights to BRII-179 and Completes Enrollment for ENRICH Study in HBV
第 1 页,共 20 页
上一页
下一页